Initial immunochemical characterization of MX35 ovarian cancer antigen

Gynecologic Oncology

Volumn 67, Issue 2, 1997, Pages 188-192

  Welshinger, Marie ^a   Yin, Beatrice W T ^a   Lloyd, Kenneth O ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL LYSATE; CELL SURFACE; DISULFIDE BOND; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IMMUNOPRECIPITATION; OVARY CANCER; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 0031281535     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4846     Document Type: Article

References (22)

1. Chatal J-F, Saccavini J-C, Gestin J-F, Thédrez P, Curtet C, Kremer M, Guerreau D, Nolibé D, Fumoleau P, Guillard Y. Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas. Cancer Res. 49:1989;3087-3094.
2. Crippa F, Buraggi G L, Di Re E, Gasparini M, Seregni E, Canevari S, Gadina M, Presti A, Marini A, Seccamani E. Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody. Eur J Cancer. 27:1991;724-729.
3. 177. Clin Cancer Res. 1:1995;1447-1454.
4. Hird V, Maraveyas A, Snook D, Dhokia B, Soutter W P, Meares C, Stewart J SW, Mason P, Lambert H E, Epenetos A A. Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. Br J Cancer. 68:1993;403-406.
5. 2. Int J Gynecol Cancer. 2:1992;23.
6. Breitz H B, Durham J S, Fisher D R, Weiden P L, DeNardo G L, Goodgold H M, Nelp W B. Pharmacokinetics and normal organ dosimetry following intraperitoneal rhenium-186-labeled monoclonal antibody. Nuclear Med. 36:1995;754-761.
7. Mattes M J, Cordon Cardo C, Lewis J LJ, Old L J, Lloyd K O. Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies. Proc Natl Acad Sci USA. 81:1984;568-572.
8. Mattes M J, Lloyd K O, Lewis J L Jr. Binding parameters of monoclonal antibodies reacting with ovarian carcinoma ascites cells. Cancer Immunol Immunother. 28:1989;199-207.
9. Rubin S C, Kostakoglu L, Divgi C, Federici M G, Finstad C L, Lloyd K O, Larson S M, Hoskins W J. Biodistribution and intraoperative evaluation of radiolabeled monoclonal antibody MX 35 in patients with epithelial ovarian cancer. Gynecol Oncol. 51:1993;61-66.
10. 2. Clin Cancer Res. 3:1997;1433-1442.
11. Hamilton T C, Young R C, Louie K G, Behrens B C, McKoy W M, Grotzinger K R, Ozols R F. Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice. Cancer Res. 44:1984;5286-5290.
12. Harlow E, Lane D. Antibodies. A Laboratory Manual. 1988;Cold Spring Harbor Laboratory, Cold Spring Harbor. p. 304-305.
13. y. Int J Cancer. 65:1996;406-412.
14. Rubin S C, Finstad C L, Hoskins W J, Federici M G, Lloyd K O, Lewis J L. A longitudinal study of antigen expression in epithelial ovarian cancer. Gynecol Oncol. 34:1989;389-394.
15. Davis H M, Zurawski V R, Bast R C, Klug T L. Characterization of the CA125 antigen associated with human epithelial ovarian cancer. Cancer Res. 46:1986;6143-6148.
16. Lloyd K O, Yin B WT, Kudryashov V. Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody (VK-8): identification as a mucin-type molecule. Int J Cancer. 71:1997;842-850.
17. Sheer D G, Schlom J, Cooper H L. Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3. Cancer Res. 48:1988;6811-6818.
18. Paxton R J, Mooser G, Pande H, Lee T D, Shively J E. Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin supergene family. Proc Natl Acad Sci USA. 84:1987;920-924.
19. Campbell I G, Jones T A, Foulkes W D, Trowsdale J. Folate-binding protein is a marker for ovarian cancer. Cancer Res. 51:1991;5329-5338.
20. Thampoe I J, Ng J SC, Lloyd K O. Biochemical analysis of a human epithelial surface antigen: Differential cell expression and processing. Arch Biochem Biophys. 267:1988;342-352.
21. Taylor-Papadimitriou J, Gendler S J. Molecular aspects of mucins. Cancer Rev. 11-12:1988;11-24.
22. Lloyd K O. Immunobiology of Ovarian Epithelial Cancer. Cancer of the Ovary. 1993;Raven Press, New York. p. 47-59.